HRX-0215 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

HRX-0215 is a small molecule inhibitor of Mitogen-Activated Protein (MAP) Kinase Kinase 4 (MKK4), a key regulator of liver regeneration. Suppression of MKK4 unlocks the regenerative capacity of hepatocytes even in severely diseased livers.

HRX-0215 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

HRX-0215 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hubei Chuchang Biotech Co., Ltd.	+undefined15623860702	info@chuchangbiotech.com	China	203	58
Hubei Chuchang Chemical Co., Ltd	18; 15623560702	Joy.Ren@aliyun.com	China	160	58
Changzhou Borl Biotechnology Co.,LTD	13606124132;13656121842	luyan0021@163.com	China	218	58
Shanghai XingMo Biotechnology Co., Ltd.	+86 13524779951; 13524779951	2075692521@qq.com	China	310	55
Shanghai Lollane Biological Technology Co.,Ltd.	021-52996696，15000506266 15000506266		China	4573	55
Shanghai Beckham Medical Technology Co., Ltd	021-13816613772 13816613772	huahero21@sina.com	China	687	55
Shanghai Rechem science Co., Ltd.	21-31433387 15618786686	sales@rechemscience.com	China	2998	58
Suzhou Rovathin Foreign Trade Co.,Ltd	0512-65816829 18662214788	info@rovathin.com.cn	China	9674	58
Jinan Jiuli Biotechnology Co. , Ltd.	15865264761	486064515@qq.com	China	5000	58
Hebei Weite Medical Technology Co., Ltd	13180081292	contact@wetogethermed.com	China	7714	58

---

• HRX-0215
• N-[2,6-Difluoro-3-[[5-(4-pyridinyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]carbonyl]phenyl]-1-propanesulfonamide
• HRX215
• Darizmetinib
• 2369583-33-3